GLP-1 drugs, including Ozempic and Wegovy from Novo Nordisk, are designed to be self-administered, with patients giving themselves shots once per week
The first batch of peptides up for discussion includes BPC-157 in ulcerative colitis, KPV in wound healing, and MOTs-C for obesity and osteoporosis
While these approaches can be effective, they often provide temporary relief and may come with side effects or risks
However, further studies are needed to fully understand their effects, particularly on EAT and HFpEF [43]
Ozempic is used to improve blood sugar control in adults with type 2 diabetes
Impact of prebiotics on enteric diseases and oxidative stress